CKD Progression and Environmental Toxicants
Chronic kidney disease (CKD) affects approximately 10% of the global population, with progression influenced by hypertension, diabetes, and increasingly recognized environmental factors. PFAS compounds accumulate in renal tissue and directly impair kidney function over time.
Tubular Toxicity Mechanisms
PFAS disrupt proximal tubular organic anion transporters, impairing renal secretion of metabolic waste products. Oxidative stress in tubular epithelial cells and mitochondrial dysfunction accelerate nephron loss in PFAS-exposed individuals.
eGFR and PFAS Associations
Longitudinal studies show faster estimated glomerular filtration rate (eGFR) decline in individuals with higher serum PFAS levels. Patients transitioning from CKD stage 2 to stage 3 show accelerated progression correlated with PFAS body burden in some cohort analyses.
Nephrology Practice Implications
Nephrologists managing CKD progression should include PFAS exposure assessment in patient workups, particularly for patients without classic CKD risk factors. Reducing PFAS exposure through clean water and dietary modification represents a modifiable factor alongside standard CKD management.